
Results
14
Financially healthy companies listed on Asian stock exchanges with an impressive track record.
14 companies
Laurus Labs
Market Cap: ₹980.5b
Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
LAURUSLABS
₹1,816.20
7D
13.4%
1Y
113.8%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$47.0b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$50.15
7D
-3.7%
1Y
97.1%
Anthem Biosciences
Market Cap: ₹455.7b
Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.
ANTHEM
₹809.20
7D
5.1%
1Y
9.6%
Emcure Pharmaceuticals
Market Cap: ₹371.6b
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
EMCURE
₹1,960.10
7D
4.2%
1Y
43.7%
Acutaas Chemicals
Market Cap: ₹254.2b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹3,104.90
7D
-4.7%
1Y
139.5%
Rubicon Research
Market Cap: ₹245.6b
Operates as a specialty pharmaceutical company in India, the United States, and internationally.
RUBICON
₹1,491.00
7D
-1.9%
1Y
n/a
Neuland Laboratories
Market Cap: ₹244.6b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹19,067.60
7D
2.7%
1Y
46.2%
Aether Industries
Market Cap: ₹204.3b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹1,539.60
7D
7.9%
1Y
104.3%
Granules India
Market Cap: ₹204.2b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.
532482
₹824.05
7D
-1.2%
1Y
82.4%
Inner Mongolia Furui Medical Science
Market Cap: CN¥12.0b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥45.38
7D
7.5%
1Y
3.8%
Shilpa Medicare
Market Cap: ₹119.6b
Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.
530549
₹611.55
7D
0.7%
1Y
42.7%
Viyash Scientific
Market Cap: ₹110.0b
Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.
512529
₹252.05
7D
0.4%
1Y
49.7%
Strides Pharma Science
Market Cap: ₹94.5b
A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.
STAR
₹1,025.00
7D
0.5%
1Y
22.5%
Sakar Healthcare
Market Cap: ₹19.7b
Research, develops, manufactures, and sells pharmaceutical products in India.
SAKAR
₹885.25
7D
10.4%
1Y
158.2%